Elaina Jurecki

1.3k total citations
31 papers, 899 citations indexed

About

Elaina Jurecki is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Elaina Jurecki has authored 31 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Clinical Biochemistry, 22 papers in Physiology and 15 papers in Molecular Biology. Recurrent topics in Elaina Jurecki's work include Metabolism and Genetic Disorders (26 papers), Diet and metabolism studies (18 papers) and Mitochondrial Function and Pathology (13 papers). Elaina Jurecki is often cited by papers focused on Metabolism and Genetic Disorders (26 papers), Diet and metabolism studies (18 papers) and Mitochondrial Function and Pathology (13 papers). Elaina Jurecki collaborates with scholars based in United States, Brazil and Canada. Elaina Jurecki's co-authors include Jessica Cohen‐Pfeffer, Fran Rohr, Mitzie Grant, Gregory M. Enns, Richard Koch, Virdette L. Brumm, Stephen D. Cederbaum, Barbara K. Burton, Deborah A. Bilder and Amarilis Sanchez‐Valle and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Pediatrics and Clinica Chimica Acta.

In The Last Decade

Elaina Jurecki

30 papers receiving 880 citations

Peers

Elaina Jurecki
Kathryn Moseley United States
C. R. Roe United States
E. Mönch Germany
F. X. Coudé France
L. Kierat Switzerland
P. J. Lee United Kingdom
M. E. J. den Boer Netherlands
Mohamed A. Nada United States
A. Kimberly Iafolla United States
B. Leiendecker Germany
Kathryn Moseley United States
Elaina Jurecki
Citations per year, relative to Elaina Jurecki Elaina Jurecki (= 1×) peers Kathryn Moseley

Countries citing papers authored by Elaina Jurecki

Since Specialization
Citations

This map shows the geographic impact of Elaina Jurecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaina Jurecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaina Jurecki more than expected).

Fields of papers citing papers by Elaina Jurecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaina Jurecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaina Jurecki. The network helps show where Elaina Jurecki may publish in the future.

Co-authorship network of co-authors of Elaina Jurecki

This figure shows the co-authorship network connecting the top 25 collaborators of Elaina Jurecki. A scholar is included among the top collaborators of Elaina Jurecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaina Jurecki. Elaina Jurecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christ, Shawn E., Georgianne L. Arnold, Uta Lichter‐Konecki, et al.. (2024). Initial results from the PHEFREE longitudinal natural history study: Cross-sectional observations in a cohort of individuals with phenylalanine hydroxylase (PAH) deficiency. Molecular Genetics and Metabolism. 143(1-2). 108541–108541.
2.
Chiesa, Ana, et al.. (2023). Adherence to PKU guidelines among patients with phenylketonuria: A cross-sectional national multicenter survey-based study in Argentina, Brazil, and Mexico. Molecular Genetics and Metabolism Reports. 38. 101026–101026. 1 indexed citations
3.
Burton, Barbara K., Anne Skalicky, Christoph Baerwald, et al.. (2021). A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials. Molecular Genetics and Metabolism Reports. 29. 100810–100810. 3 indexed citations
4.
Quinn, Jennifer, Alexandros Georgiadis, Hannah B Lewis, & Elaina Jurecki. (2021). Measuring Burden of Illness in Phenylketonuria (PKU): Development of the PKU Symptom Severity and Impacts Scale as a Robust Patient-Reported Outcome. Advances in Therapy. 39(2). 971–991. 11 indexed citations
5.
Bilder, Deborah A., Georgianne L. Arnold, David Dimmock, et al.. (2021). Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria. American Journal of Medical Genetics Part A. 188(3). 768–778. 17 indexed citations
6.
Jurecki, Elaina, Keiko Ueda, Dianne M. Frazier, et al.. (2019). Nutrition management guideline for propionic acidemia: An evidence- and consensus-based approach. Molecular Genetics and Metabolism. 126(4). 341–354. 40 indexed citations
7.
Zori, Roberto T., Kirsten Ahring, Barbara K. Burton, et al.. (2019). Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria. Molecular Genetics and Metabolism. 128(1-2). 92–101. 19 indexed citations
8.
Burton, Barbara K., Kyle Bradford Jones, Stephen D. Cederbaum, et al.. (2018). Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria. Molecular Genetics and Metabolism. 125(3). 228–234. 69 indexed citations
9.
Jurecki, Elaina, Stephen D. Cederbaum, Fran Rohr, et al.. (2017). Adherence to clinic recommendations among patients with phenylketonuria in the United States. Molecular Genetics and Metabolism. 120(3). 190–197. 135 indexed citations
10.
Jurecki, Elaina, et al.. (2017). Development of the US English version of the phenylketonuria – quality of life (PKU-QOL) questionnaire. Health and Quality of Life Outcomes. 15(1). 46–46. 10 indexed citations
11.
Hendriksz, Christian J., Rossella Parini, Moeenaldeen AlSayed, et al.. (2016). Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome. Molecular Genetics and Metabolism. 119(1-2). 131–143. 50 indexed citations
12.
Longo, Nicola, Komudi Siriwardena, Annette Feigenbaum, et al.. (2014). Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy. Genetics in Medicine. 17(5). 365–373. 21 indexed citations
13.
Jurecki, Elaina, et al.. (2014). Sapropterin Dihydrochloride Mixed With Common Foods and Beverages. Topics in Clinical Nutrition. 29(4). 325–331. 1 indexed citations
14.
Berry, Susan A., Christine Brown, Mitzie Grant, et al.. (2013). Newborn screening 50 years later: access issues faced by adults with PKU. Genetics in Medicine. 15(8). 591–599. 92 indexed citations
15.
Cunningham, Amy, Mary M. Brown, Sharon L. Ernst, et al.. (2012). Recommendations for the use of sapropterin in phenylketonuria. Molecular Genetics and Metabolism. 106(3). 269–276. 35 indexed citations
16.
Gordon, Patricia, et al.. (2012). Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients. Molecular Genetics and Metabolism. 105(4). 672–676. 10 indexed citations
17.
Burton, Barbara K., et al.. (2010). Tetrahydrobiopterin Therapy for Phenylketonuria in Infants and Young Children. The Journal of Pediatrics. 158(3). 410–415. 23 indexed citations
18.
Singh, Rani H., Elaina Jurecki, & Fran Rohr. (2008). Recommendations for Personalized Dietary Adjustments Based on Patient Response to Tetrahydrobiopterin (BH4) in Phenylketonuria. Topics in Clinical Nutrition. 23(2). 149–157. 15 indexed citations
19.
Acosta, Phyllis B., Steven Yannicelli, Rani H. Singh, et al.. (2003). Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. Journal of the American Dietetic Association. 103(9). 1167–1173. 70 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathryn Moseley Breakdown of academic impact, for papers by C. R. Roe Breakdown of academic impact, for papers by E. Mönch Breakdown of academic impact, for papers by F. X. Coudé Breakdown of academic impact, for papers by L. Kierat Breakdown of academic impact, for papers by P. J. Lee Breakdown of academic impact, for papers by M. E. J. den Boer Breakdown of academic impact, for papers by Mohamed A. Nada Breakdown of academic impact, for papers by A. Kimberly Iafolla Breakdown of academic impact, for papers by B. Leiendecker
Rankless by CCL
2026